Physician profile
Andrew W Maples
NPI 1245472802
$2,186.38
in general payments reported to CMS, 2019-2025
10 companies · $52.06 in 2025
The $52.06 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $232 · 2021: $387 · 2022: $878 · 2023: $411 · 2024: $30.82 · 2025: $52.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Entertainment: $396 · Food and Beverage: $97.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Entertainment | $396.30 |
| Food and Beverage | $97.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $1,665.95 | 2019-2023 | |
| Ultradent Products INC | $225.98 | 2022 | |
| Henry Schein, INC. | $96.11 | 2019 | |
| Zimmer Biomet Holdings, INC. | $56.40 | 2021 | |
| Zimvie INC. | $45.68 | 2024-2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $37.20 | 2025 | Arestin |
| Voco America INC. | $24.19 | 2020-2023 | Bifix Qm, Futurabond U, Meron Plus Qm |
| Dentsply Sirona INC | $12.07 | 2020 | |
| Philips North America LLC | $12.00 | 2019 | |
| Dentsply Sirona Orthodontics INC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Maples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.